Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2–, PIK3CA-mutated breast cancers

Press/Media

Period26 Apr 2023

Media coverage

1

Media coverage

  • TitleMultiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2–, PIK3CA-mutated breast cancers
    Media name/outletGenomebiology.Biomedcentral.com
    Country/TerritoryUnited Kingdom
    Date26/04/23
    PersonsYAPENG WANG
View all 1
View less